NPPB and cardiac hypertrophy: In addition, it would be interesting from the clinical point of view to know whether the variability in NT-proBNP levels is associated to events occurring after the 2 years of the study in both the populations studied (hypertensive patients with and without hypertrophy), however, this study was designed and funded only for a 2-year follow-up.